ZA964209B - Benzopyrans. - Google Patents

Benzopyrans.

Info

Publication number
ZA964209B
ZA964209B ZA9604209A ZA964209A ZA964209B ZA 964209 B ZA964209 B ZA 964209B ZA 9604209 A ZA9604209 A ZA 9604209A ZA 964209 A ZA964209 A ZA 964209A ZA 964209 B ZA964209 B ZA 964209B
Authority
ZA
South Africa
Prior art keywords
benzopyrans
Prior art date
Application number
ZA9604209A
Other languages
English (en)
Inventor
Paul W Manley
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA964209(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA964209B publication Critical patent/ZA964209B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA9604209A 1995-05-24 1996-05-24 Benzopyrans. ZA964209B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds

Publications (1)

Publication Number Publication Date
ZA964209B true ZA964209B (en) 1997-11-24

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9604209A ZA964209B (en) 1995-05-24 1996-05-24 Benzopyrans.

Country Status (30)

Country Link
US (1) US5905156A (fr)
EP (1) EP0828733B1 (fr)
JP (1) JPH11505820A (fr)
KR (1) KR100437981B1 (fr)
CN (1) CN1077888C (fr)
AR (1) AR004489A1 (fr)
AT (1) ATE205204T1 (fr)
AU (1) AU703276B2 (fr)
BR (1) BR9609048A (fr)
CA (1) CA2217821C (fr)
CO (1) CO4700520A1 (fr)
CZ (1) CZ294474B6 (fr)
DE (1) DE69615019T2 (fr)
DK (1) DK0828733T3 (fr)
ES (1) ES2163634T3 (fr)
FI (1) FI973992A7 (fr)
GB (1) GB9510477D0 (fr)
HU (1) HU222772B1 (fr)
IL (1) IL118382A (fr)
MY (1) MY114924A (fr)
NO (1) NO314846B1 (fr)
NZ (1) NZ309765A (fr)
PL (1) PL184144B1 (fr)
PT (1) PT828733E (fr)
RU (1) RU2160735C2 (fr)
SK (1) SK283215B6 (fr)
TR (1) TR199701417T1 (fr)
TW (1) TW421646B (fr)
WO (1) WO1996037490A1 (fr)
ZA (1) ZA964209B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
ES2353383T3 (es) * 2002-08-29 2011-03-01 Nissan Chemical Industries, Ltd. Procedimiento de producción de un compuesto de aminobenzopirano.
US7098340B2 (en) * 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
JP6987746B2 (ja) 2015-09-28 2022-01-05 ジェネンテック， インコーポレイテッド 治療用化合物及びその使用方法
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
EP3601273B1 (fr) 2017-03-24 2021-12-01 Genentech, Inc. Dérivés de 4-pipéridine-n-(pyrimidin-4-yl) chromane-7-sulfonamide en tant qu'inhibiteurs de canaux sodiques
TW202003490A (zh) 2018-05-22 2020-01-16 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
GB9102803D0 (en) * 1991-02-11 1991-03-27 Ici Plc Pyridine compounds
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (fr) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
CZ294474B6 (cs) 2005-01-12
PL324042A1 (en) 1998-05-11
SK157797A3 (en) 1998-05-06
TR199701417T1 (xx) 1998-02-21
NO975365D0 (no) 1997-11-21
FI973992A0 (fi) 1997-10-17
JPH11505820A (ja) 1999-05-25
CN1185153A (zh) 1998-06-17
DK0828733T3 (da) 2001-12-17
TW421646B (en) 2001-02-11
CA2217821A1 (fr) 1996-11-28
NZ309765A (en) 2000-01-28
CO4700520A1 (es) 1998-12-29
PL184144B1 (pl) 2002-09-30
FI973992L (fi) 1997-12-09
US5905156A (en) 1999-05-18
CZ368897A3 (cs) 1998-02-18
AU703276B2 (en) 1999-03-25
MY114924A (en) 2003-02-28
ES2163634T3 (es) 2002-02-01
EP0828733A1 (fr) 1998-03-18
MX9709004A (es) 1998-03-31
WO1996037490A1 (fr) 1996-11-28
BR9609048A (pt) 1999-02-23
DE69615019D1 (de) 2001-10-11
HUP9801751A2 (hu) 1999-06-28
HK1014137A1 (en) 1999-09-24
IL118382A (en) 2000-01-31
NO314846B1 (no) 2003-06-02
KR100437981B1 (ko) 2004-07-16
ATE205204T1 (de) 2001-09-15
HU222772B1 (hu) 2003-10-28
KR19990021925A (ko) 1999-03-25
EP0828733B1 (fr) 2001-09-05
IL118382A0 (en) 1996-09-12
GB9510477D0 (en) 1995-07-19
PT828733E (pt) 2002-02-28
CN1077888C (zh) 2002-01-16
AU6000896A (en) 1996-12-11
SK283215B6 (sk) 2003-03-04
FI973992A7 (fi) 1997-12-09
CA2217821C (fr) 2008-05-06
RU2160735C2 (ru) 2000-12-20
DE69615019T2 (de) 2002-06-06
HUP9801751A3 (en) 1999-08-30
AR004489A1 (es) 1998-12-16
NO975365L (no) 1998-01-15

Similar Documents

Publication Publication Date Title
ZA967315B (en) Biphenylamides.
MX213417B (es) Fenilpiridazinonas.
ZA961444B (en) Pyrazolylbenzoyl derivatives.
ZA9610858B (en) Heteroclyclic compounds.
ZA961446B (en) Phenyldiketone derivates.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
ZA965505B (en) Novel compounds.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
ZA966676B (en) Bacteriocin.
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA967741B (en) Diarylalkenylamine derivatives.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
ZA966399B (en) Endothelin-receptor-antagonists.
ZA964560B (en) Anit-viral compounds.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
ZA964264B (en) Retinoid-like compounds.
ZA968941B (en) Peroxyacids.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA966750B (en) Halogenobenzimidazoles.
ZA969923B (en) Antioxidant.
ZA967314B (en) Carbamoylcarboxamides.
ZA964034B (en) N-aminopyridone derivatives.